Atossa Therapeutics Inc (ATOS) Implied Volatility Current

Tracking ATOS implied volatility helps you identify when options premiums on Atossa Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Atossa Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when ATOS IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Atossa Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ATOS, tracking metrics like ATOS IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ATOS signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc.

was founded in 2008 and is based in Seattle, Washington.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ATOS implied volatility sits today versus where it has been. Our scanner ranks Atossa Therapeutics Inc implied volatility against its historical range, surfaces extremes in ATOS IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Atossa Therapeutics Inc IV is rich or cheap — measure it, then act on it.